144 related articles for article (PubMed ID: 37705026)
1. Receptor conversion and survival in breast cancer liver metastases.
Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Front Oncol; 2021; 11():670723. PubMed ID: 34046360
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study.
Xiao W; Zheng S; Liu P; Zou Y; Xie X; Yu P; Tang H; Xie X
Cancer Med; 2018 Mar; 7(3):922-930. PubMed ID: 29473333
[TBL] [Abstract][Full Text] [Related]
5. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.
Chun YS; Mizuno T; Cloyd JM; Ha MJ; Omichi K; Tzeng CD; Aloia TA; Ueno NT; Kuerer HM; Barcenas CH; Vauthey JN
Eur J Surg Oncol; 2020 Sep; 46(9):1588-1595. PubMed ID: 32253074
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Xu B
BMC Cancer; 2021 Dec; 21(1):1330. PubMed ID: 34906122
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
[TBL] [Abstract][Full Text] [Related]
8. Evolving Role of Liver Resection in Selected Patients With Metastatic Breast Cancer.
Millen JA; Hofmann A; Mesquita-Neto JW; Rose J; Macedo FI
J Surg Res; 2021 Mar; 259():363-371. PubMed ID: 33189360
[TBL] [Abstract][Full Text] [Related]
9. Aggressive treatment for hepatic metastases from breast cancer: results from a single center.
Polistina F; Costantin G; Febbraro A; Robusto E; Ambrosino G
World J Surg; 2013 Jun; 37(6):1322-32. PubMed ID: 23474856
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
[No Abstract] [Full Text] [Related]
11. Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control study.
Sundén M; Hermansson C; Taflin H; Andersson A; Sund M; Hemmingsson O
Eur J Surg Oncol; 2020 Jun; 46(6):1006-1012. PubMed ID: 32098734
[TBL] [Abstract][Full Text] [Related]
12. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.
Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G
Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227
[TBL] [Abstract][Full Text] [Related]
13. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.
Zhao HY; Gong Y; Ye FG; Ling H; Hu X
Cancer Manag Res; 2018; 10():5937-5950. PubMed ID: 30538544
[TBL] [Abstract][Full Text] [Related]
15. Web-Based Dynamic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Breast Cancer Patients with Lung Metastases.
Wang K; Li Y; Wang D; Zhou Z
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675704
[TBL] [Abstract][Full Text] [Related]
16. Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution.
Chen R; Qarmali M; Siegal GP; Wei S
Mod Pathol; 2020 Dec; 33(12):2499-2506. PubMed ID: 32620918
[TBL] [Abstract][Full Text] [Related]
17. The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment.
Wen J; Ye F; Xie F; Liu D; Huang L; Fang C; Zhong S; Ren L
Cancer Med; 2020 Jul; 9(13):4656-4666. PubMed ID: 32396284
[TBL] [Abstract][Full Text] [Related]
18. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto W; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; Yu J; Chiang V; Nakano T; Aoyama H; Mehta MP
Neuro Oncol; 2020 Sep; 22(9):1359-1367. PubMed ID: 32034917
[TBL] [Abstract][Full Text] [Related]
19. Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
Yi ZB; Yu P; Zhang S; Wang WN; Han YQ; Ouyang QC; Yan M; Wang XJ; Hu XC; Jiang ZF; Huang T; Tong ZS; Wang SS; Yin YM; Li H; Yang RX; Yang HW; Teng YE; Sun T; Cai L; Li HY; Chen X; He JJ; Liu XL; Yang SE; Wang JY; Fan JH; Qiao YL; Xu BH
Int J Cancer; 2021 Feb; 148(3):692-701. PubMed ID: 32700765
[TBL] [Abstract][Full Text] [Related]
20. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
